The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases.

Habibie, Habibie; Adhyatmika, Adhyatmika; Schaafsma, Dedmer; Melgert, Barbro N

Habibie, Habibie; Adhyatmika, Adhyatmika; Schaafsma, Dedmer; Melgert, Barbro N.

Afiliación

Habibie H; University of Groningen, Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands; Hasanuddin University, Faculty of Pharmacy, Makassa
Adhyatmika A; Gadjah Mada University, Department of Pharmaceutics, Faculty of Pharmacy, Yogyakarta, Indonesia.
Schaafsma D; Science Impact, Winnipeg, Canada.
Melgert BN; University of Groningen, Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands. Electronic address: b.n.melgert@rug.nl.

Pharmacol Ther ; 228: 107941, 2021 12.

Article en En | MEDLINE | ID: mdl-34171336

Asunto(s)

Fibrosis; Osteoprotegerina; Biomarcadores; Fibrosis/diagnóstico; Fibrosis/tratamiento farmacológico; Fibrosis/fisiopatología; Humanos; Osteoprotegerina/efectos de los fármacos; Osteoprotegerina/fisiología

Palabras clave

Fibroblast; Lung; RANKL; TGFß; TNFRSF11B; TRAIL

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis / Osteoprotegerina Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google